Hyaluronic Acid Injectable Gel
DeviceHyaluronic Acid Injectable Gel (VYC-25L) injection into the chin and/or jaw areas (up to 4.0 mLs).
NCT Number: NCT02559908
This study will evaluate the safety and performance of VYC-25L hyaluronic acid injectable gel for the restoration and creation of facial volume in participants seeking to increase projection of the chin and/or jaw.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cabinet medical Solferino, Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-Has chin retrusion.
Exclusion criteria
Hyaluronic Acid Injectable Gel (VYC-25L) injection into the chin and/or jaw areas (up to 4.0 mLs).
Time frame: Baseline, Month 3
Time frame: Month 3
Time frame: Month 3
Allergan
Industry
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of VYC-25L Hyaluronic Acid Injectable Gel for Restoration and Creation of Facial Volume in the Chin and Jaw
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05777759
Chin Augmentation, Chin Retrusion
Los Angeles, California, United States
View Trial DetailsNCT06336772
Chin Retrusion
Montreal, Quebec, Canada
View Trial DetailsNCT03597256
Chin Retrusion
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04559984
Chin Retrusion
Beijing, Beijing Municipality, China
View Trial Details